10-Q Filing

PFIZER INC CIK: 78003 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0000078003-21-000107`
Period End Date	20210930
Filing Date	20211112
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	pfe-20211003_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 92 Cash Flow Statement 94 Stockholders Equity 52 Comprehensive Income 72

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$508.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$494.00M	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$14.81B	USD	Point-in-time
Property, plant and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.40B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.97B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.78B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$27.73B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.66B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.00B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$10.44B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2021$494; 2020$508	`AccountsReceivableNetCurrent`	$7.93B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2021$494; 2020$508	`AccountsReceivableNetCurrent`	$11.90B	USD	Point-in-time
Inventories	`InventoryNet`	$8.05B	USD	Point-in-time
Inventories	`InventoryNet`	$8.64B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.88B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.26B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.60B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.79B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$57.90B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$35.07B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.86B	USD	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.35B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$3.41B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$5.25B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2021$15,403; 2020$14,812	`PropertyPlantAndEquipmentNet`	$14.44B	USD	Point-in-time
Property, plant and equipment, less accumulated depreciation: 2021$15,403; 2020$14,812	`PropertyPlantAndEquipmentNet`	$13.90B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$28.47B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$26.31B	USD	Point-in-time
Goodwill	`Goodwill`	$49.58B	USD	Point-in-time
Goodwill	`Goodwill`	$49.49B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$2.38B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$2.75B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$6.71B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$4.57B	USD	Point-in-time
Total assets	`Assets`	$179.19B	USD	Point-in-time
Total assets	`Assets`	$154.23B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2021$2,663; 2020$2,002	`DebtCurrent`	$3.63B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2021$2,663; 2020$2,002	`DebtCurrent`	$2.70B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$4.31B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$4.70B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.16B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.19B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.05B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$4.50B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$2.57B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.06B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$3.53B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$1.11B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$20.69B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$11.53B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$25.92B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$41.80B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$37.13B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$36.25B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$4.77B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$3.68B	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$627.00M	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$645.00M	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$328.00M	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$4.06B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.34B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.56B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$9.20B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$6.67B	USD	Point-in-time
Total liabilities	`Liabilities`	$103.22B	USD	Point-in-time
Total liabilities	`Liabilities`	$90.76B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$470.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$473.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.67B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$89.97B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$110.99B	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$111.36B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$90.39B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$102.25B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.31B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.65B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$75.69B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$63.24B	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$235.00M	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$275.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.57B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.50B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.97B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$179.19B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$154.23B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$10.28B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$24.09B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$30.22B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$57.65B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.01B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$9.97B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$5.77B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$21.23B	USD	3 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$7.86B	USD	3 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.90B	USD	1 Quarter
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$8.62B	USD	3 Qtrs
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.66B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.05B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.45B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$2.30B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$7.92B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$981.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$2.58B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$2.78B	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$862.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$417.00M	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$668.00M	USD	3 Qtrs
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$2.00M	USD	1 Quarter
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$646.00M	USD	1 Quarter
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	$6.00M	USD	3 Qtrs
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	1 Quarter
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$1.70B	USD	1 Quarter
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-1.11B	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$3.70B	USD	3 Qtrs
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-1.88B	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$20.13B	USD	3 Qtrs
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.44B	USD	3 Qtrs
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.84B	USD	1 Quarter
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$570.00M	USD	1 Quarter
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$-331.00M	USD	1 Quarter
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$434.00M	USD	3 Qtrs
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$-347.00M	USD	1 Quarter
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$1.52B	USD	3 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.17B	USD	1 Quarter
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$18.61B	USD	3 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.00B	USD	3 Qtrs
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$917.00M	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$24.00M	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.33B	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$560.00M	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-9.00M	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$1.48B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.34B	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$47.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$25.00M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$12.00M	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$18.59B	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$1.47B	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$8.31B	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$8.15B	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$3.32	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.08	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.16	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.45	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.42	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.10	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.45	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.26	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.50	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$3.32	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.16	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.42	USD	1 Quarter
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.06	USD	3 Qtrs
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.26	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.10	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.42	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.26	USD	1 Quarter
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$3.27	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.48	USD	3 Qtrs
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.42	USD	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.55B	shares	3 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.60B	shares	3 Qtrs
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.56B	shares	1 Quarter
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.61B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.62B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.69B	shares	3 Qtrs
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.72B	shares	1 Quarter
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.63B	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$1.48B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.34B	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-9.00M	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$560.00M	USD	1 Quarter
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.33B	USD	3 Qtrs
Income/(loss) from discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$24.00M	USD	3 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$917.00M	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$8.17B	USD	1 Quarter
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$18.61B	USD	3 Qtrs
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.00B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$3.57B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$3.91B	USD	3 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$115.00M	USD	3 Qtrs
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$989.00M	USD	3 Qtrs
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	-	USD	3 Qtrs
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	$6.00M	USD	3 Qtrs
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$-3.70B	USD	3 Qtrs
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$-735.00M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$687.00M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$468.00M	USD	3 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$760.00M	USD	3 Qtrs
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$1.93B	USD	3 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$1.85B	USD	3 Qtrs
Other adjustments, net	`OtherNoncashIncomeExpense`	$313.00M	USD	3 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$-10.82B	USD	3 Qtrs
Other changes in assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOperatingCapital`	$2.86B	USD	3 Qtrs
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$6.36B	USD	3 Qtrs
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$26.66B	USD	3 Qtrs
Net cash provided by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$6.00M	USD	3 Qtrs
Net cash provided by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$2.41B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$26.67B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.78B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.72B	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.41B	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$26.28B	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$9.31B	USD	3 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$8.40B	USD	3 Qtrs
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$15.85B	USD	3 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$7.15B	USD	3 Qtrs
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$-671.00M	USD	3 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$284.00M	USD	3 Qtrs
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$861.00M	USD	3 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$648.00M	USD	3 Qtrs
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$569.00M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-160.00M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$370.00M	USD	3 Qtrs
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-19.96B	USD	3 Qtrs
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.13B	USD	3 Qtrs
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-11.47B	USD	3 Qtrs
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.96B	USD	3 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.60B	USD	3 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$12.35B	USD	3 Qtrs
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	-	USD	3 Qtrs
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$17.45B	USD	3 Qtrs
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$1.00M	USD	3 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$265.00M	USD	3 Qtrs
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$1.62B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$997.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.22B	USD	3 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.00B	USD	3 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$2.51B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$6.33B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$6.54B	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-185.00M	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-166.00M	USD	3 Qtrs
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-6.46B	USD	3 Qtrs
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-7.26B	USD	3 Qtrs
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$11.39B	USD	3 Qtrs
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.14B	USD	3 Qtrs
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.46B	USD	3 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-32.00M	USD	3 Qtrs
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-39.00M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$209.00M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$277.00M	USD	3 Qtrs
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.03B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.03B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$2.94B	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	$2.44B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.30B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.21B	USD	3 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$-26.00M	USD	3 Qtrs
Interest rate hedges	`InterestPaidReceivedInterestRateHedges`	$-45.00M	USD	3 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$157.00M	USD	3 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55B	USD	3 Qtrs

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.14	USD	3 Qtrs
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.17	USD	3 Qtrs
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.39	USD	1 Quarter
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.38	USD	1 Quarter
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.57B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.50B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.97B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Net income	`ProfitLoss`	$8.34B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.48B	USD	1 Quarter
Net income	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income	`ProfitLoss`	$8.16B	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-329.00M	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-338.00M	USD	3 Qtrs
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$1.30B	USD	1 Quarter
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-894.00M	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$2.11B	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$6.57B	USD	3 Qtrs
Common stock	`DividendsCommonStockCash`	$2.19B	USD	1 Quarter
Common stock	`DividendsCommonStockCash`	$6.41B	USD	3 Qtrs
Preferred stock	`DividendsPreferredStockCash`	-	USD	3 Qtrs
Preferred stock	`DividendsPreferredStockCash`	-	USD	1 Quarter
Preferred stock	`DividendsPreferredStockCash`	-	USD	3 Qtrs
Preferred stock	`DividendsPreferredStockCash`	-	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	3 Qtrs
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$81.00M	USD	3 Qtrs
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	1 Quarter
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$1.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$855.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$539.00M	USD	3 Qtrs
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$273.00M	USD	1 Quarter
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$634.00M	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	3 Qtrs
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	$1.00M	USD	3 Qtrs
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	-	USD	3 Qtrs
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	-	USD	1 Quarter
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	-	USD	1 Quarter
Other	`StockholdersEquityOther`	$1.00M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$79.00M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$46.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.57B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.31B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.50B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.97B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time

Comprehensive Income 72 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.16B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$18.63B	USD	3 Qtrs
Net income before allocation to noncontrolling interests	`ProfitLoss`	$1.48B	USD	1 Quarter
Net income before allocation to noncontrolling interests	`ProfitLoss`	$8.34B	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-27.00M	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-866.00M	USD	1 Quarter
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-366.00M	USD	3 Qtrs
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$1.40B	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$-372.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$179.00M	USD	3 Qtrs
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$213.00M	USD	1 Quarter
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$-661.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-286.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-143.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-48.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$25.00M	USD	3 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-685.00M	USD	3 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$261.00M	USD	1 Quarter
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$464.00M	USD	3 Qtrs
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-230.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-266.00M	USD	1 Quarter
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$231.00M	USD	3 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-128.00M	USD	3 Qtrs
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$239.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-9.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$85.00M	USD	1 Quarter
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$172.00M	USD	3 Qtrs
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$25.00M	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-257.00M	USD	1 Quarter
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$205.00M	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-300.00M	USD	3 Qtrs
Other comprehensive income (loss), available-for-sale securities, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$155.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-45.00M	USD	1 Quarter
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-119.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-134.00M	USD	3 Qtrs
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-39.00M	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	-	USD	3 Qtrs
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-59.00M	USD	3 Qtrs
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	-	USD	1 Quarter
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-59.00M	USD	1 Quarter
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$-2.00M	USD	1 Quarter
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$-1.00M	USD	3 Qtrs
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$3.00M	USD	3 Qtrs
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$3.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$47.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$97.00M	USD	1 Quarter
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$181.00M	USD	3 Qtrs
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$133.00M	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$1.28B	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-640.00M	USD	3 Qtrs
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-959.00M	USD	1 Quarter
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-382.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-19.00M	USD	1 Quarter
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-44.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-311.00M	USD	3 Qtrs
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-65.00M	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-329.00M	USD	3 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-338.00M	USD	3 Qtrs
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$1.30B	USD	1 Quarter
Other comprehensive income/(loss) before allocation to noncontrolling interests	`OtherComprehensiveIncomeLossNetOfTax`	$-894.00M	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$18.30B	USD	3 Qtrs
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.78B	USD	1 Quarter
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$8.01B	USD	3 Qtrs
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.26B	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$48.00M	USD	3 Qtrs
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$9.00M	USD	1 Quarter
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$16.00M	USD	3 Qtrs
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$2.77B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$18.25B	USD	3 Qtrs
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$7.26B	USD	1 Quarter
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$7.99B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.